ARCHIVES

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director

March 17, 1995

NCI advisors seek comment on clinical trials system, until Jan. 15.

December 10, 2004

In Brief: Sparano Named Vice Chair of ECOG-ACRIN

May 17, 2013

I-ELCAP Moves From Weill Cornell To Arizona State; PIs Move To Mount Sinai.

January 22, 2010

Momentum Continues For Private Development Of Free Standing Cancer Centers

July 19, 1985

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014